Literature DB >> 7907354

Genetic structures of the B2 and B1 Escherichia coli strains responsible for extra-intestinal infections.

B Picard1, C Journet-Mancy, N Picard-Pasquier, P Goullet.   

Abstract

Escherichia coli strains causing human extra-intestinal infections may be divided into two groups, B1 and B2 according to the electrophoretic patterns of carboxylesterase B. This study compares the restriction fragment length polymorphism (RFLP) of ribosomal DNA (rDNA) for 45 B1 strains and 45 B2 strains to examine the genetic structure of B2 strains and to distinguish them from B1 strains. The isolates were chosen for diversity in their allozymes of esterases, B, A, C and I, their production of virulence factors (alpha-haemolysin, mannose resistant haemagglutinin and cytotoxic necrotizing factor) and certain O antigens, and their pathological and geographical origins. DNA was digested with HindIII and BamHI restriction enzymes and analysed by Southern blotting. The resulting rDNA RFLP patterns of B2 strains were distinct from those of the B1 strains. Moreover, the B2 strains appeared to be less heterogeneous than the B1 strains. The B2 strains gave 13 ribotypes (resulting from the combination of the rDNA RFLP patterns obtained with HindIII and BamHI digestions) while the B1 strains gave 32 ribotypes. Correspondence analysis of the data showed that several clusters of strains were identified in the B2 strains by particular ribotypes, certain associations of esterase B and A electrophoretic variants, O serotypes and virulence factor production. In contrast, these parameters appeared to be unrelated in the B1 strains, reflecting their heterogeneity. These findings, which differentiate two levels of genetic heterogeneity within E. coli pathogenic isolates, indicate that the B2 strains constitute a phylogenetically distinct group within the species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7907354     DOI: 10.1099/00221287-139-12-3079

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  6 in total

1.  Automated ribotyping provides rapid phylogenetic subgroup affiliation of clinical extraintestinal pathogenic Escherichia coli strains.

Authors:  O Clermont; C Cordevant; S Bonacorsi; A Marecat; M Lange; E Bingen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.

Authors:  J R Johnson; T T O'Bryan; M Kuskowski; J N Maslow
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IIJ96-like domains among Escherichia coli strains of different clinical origins.

Authors:  Philippe Bidet; Stéphane Bonacorsi; Olivier Clermont; Caroline De Montille; Naima Brahimi; Edouard Bingen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Sex in Escherichia coli does not disrupt the clonal structure of the population: evidence from random amplified polymorphic DNA and restriction-fragment-length polymorphism.

Authors:  P Desjardins; B Picard; B Kaltenböck; J Elion; E Denamur
Journal:  J Mol Evol       Date:  1995-10       Impact factor: 2.395

5.  The link between phylogeny and virulence in Escherichia coli extraintestinal infection.

Authors:  B Picard; J S Garcia; S Gouriou; P Duriez; N Brahimi; E Bingen; J Elion; E Denamur
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

6.  The plasmid of Escherichia coli strain S88 (O45:K1:H7) that causes neonatal meningitis is closely related to avian pathogenic E. coli plasmids and is associated with high-level bacteremia in a neonatal rat meningitis model.

Authors:  Chantal Peigne; Philippe Bidet; Farah Mahjoub-Messai; Céline Plainvert; Valérie Barbe; Claudine Médigue; Eric Frapy; Xavier Nassif; Erick Denamur; Edouard Bingen; Stéphane Bonacorsi
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.